Kojiro Michitaka - Concepedia

Author

Kojiro Michitaka

Also Known As

K Joko, K Kudou, K MICHITAKA, K Michitaka, K. MICHITAKA, K. Michitaka, KOJIRO MICHITAKA, Kojiro MICHITAKA, Kojiro Michitaka, M Abe

379

Publications

7.9K

Citations

H-Index

126

Concepts

All Affiliations

Ehime University Ehime Prefectural Central Hospital Matsuyama Red Cross Hospital Ogaki Municipal Hospital Teine Keijinkai Hospital

About

Kojiro Michitaka is an author at Ehime University specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	51	1.9K
2	Health Sciences	9	9	415
3	Public Health	3	3	77
4	Allergy	2	2	34
5	Biomedical Engineering	1	1	34

Kojiro Michitaka

153

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function Atsushi Hiraoka, Kojiro Michitaka, Takashi Kumada, Liver Cancer	2017	319
Usefulness of albumin–bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma Atsushi Hiraoka, Takashi Kumada, Kojiro Michitaka, Journal of Gastroenterology and Hepatology	2015	243
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis Atsushi Hiraoka, Takashi Kumada, Kunihiko Tsuji, Liver Cancer	2018	230
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo, Liver Cancer	2017	208
A Technique for the Measurement of Visceral Fat by Ultrasonography: Comparison of Measurements by Ultrasonography and Computed Tomography Masashi Hirooka, Teru Kumagi, Kiyotaka Kurose, Internal Medicine	2005	164
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis Atsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, Cancer Medicine	2019	158
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo, Digestive Diseases Surgical OncologySorafenib TreatmentPathologyHepatic FunctionHcc Patients	2017	144
Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis Atsushi Hiraoka, Kojiro Michitaka, Daisuke Kiguchi, European Journal of Gastroenterology & Hepatology	2017	131
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis Atsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, Cancer Medicine	2018	130
Anti-HBs-Positive Liver Failure Due to Hepatitis B Virus Reactivation Induced by Rituximab Toshiki Sera, Yoichi Hiasa, Kojiro Michitaka, Internal Medicine ImmunologyHepatitis BPathologyImmunotherapyAutoimmune Liver Disease	2006	126

Page 1